Shilpa Medicare has informed that it enclosed the revised Disclosures of reasons for encumbrance by promoter of listed companies under Regulation 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 26, 2024 for Ramakant Innani.
The above information is a part of company’s filings submitted to BSE.